Afuco™ Anti-MST1R ADCC Therapeutic Antibody (Narnatumab), ADCC Enhanced

This product is an ADCC enhanced antibody produced by our Afuco™ platform. Recombinant monoclonal antibody to RON. Narnatumab is a human monoclonal antibody designed for the treatment of cancer.
Supplier Creative Biolabs
Product # AFC-TAB-184
Pricing Inquiry
Host Human
Target MST1R
Species Reactivity Human
Type ADCC enhanced antibody
Applications FuncS, IF, Neut, ELISA, FC, IP
Storage Store at +4°C short term (1-2 weeks). Aliquot and store at -20°C long term. Avoid repeated freeze/thaw cycles.
Feedback